![](https://www.udayavani.com/wp-content/uploads/2024/09/Gen-Asim-Munir-Wikimedia-Commons-415x275.jpg)
Zydus Cadila launches COVID-19 drug Remdesivir in India
PTI, Aug 13, 2020, 10:38 AM IST
![](https://www.udayavani.com/wp-content/uploads/2020/08/Remdesivir-1-620x343.jpg)
New Delhi: Drug firm Zydus Cadila on Thursday, August 13 said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in the Indian market.
Priced at Rs 2,800 per 100 mg vial, Remdac is the most economical Remdesivir brand in India, Zydus Cadila said in a regulatory filing.
The company said the drug will be made available across India through the group”s strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.
“Remdac is the most affordable drug as we would like to enable patients to have access to this critical drug in the treatment of COVID-19,” Cadila Healthcare Managing Director Dr. Sharvil Patel said.
“Through the course of this pandemic, the company’s efforts have been focused on supporting people in this healthcare crisis, whether it is through developing vaccines, ramping up production and distribution of critical drugs and therapies, making diagnostic tests available, or exploring new treatment options,” Patel added.
In June this year, Zydus had entered into a non-exclusive agreement with Gilead Sciences Inc to manufacture and sell Remdesivir, the investigational drug, which has been issued an emergency use authorization by the US Food and Drug Administration (USFDA) to treat patients suffering from severe symptoms of COVID-19.
The active pharmaceutical ingredient (API) for the drug has been developed and manufactured at the group”s API manufacturing facilities in Gujarat.
Zydus Cadila”s vaccine candidate ZyCov-D is now in phase II of the clinical trials.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
![](https://www.udayavani.com/wp-content/uploads/2023/05/IndianClicks_GVega_Udayavani_300x250_12032021_1_1.gif)
Related Articles More
![](https://www.udayavani.com/wp-content/uploads/2024/09/byju-150x84.png)
Byju’s auditor suggested backdating reports; resignation more of optics: Byju Raveendran
![](https://www.udayavani.com/wp-content/uploads/2024/09/Screenshot_2024-09-07-13-22-54-00_40deb401b9ffe8e1df2f1cc5ba480b12-125x115.jpg)
Wockhardt denies allegations of rent payment by Carol Info, its connection with SEBI orders
![](https://www.udayavani.com/wp-content/uploads/2024/09/House-sold-Pexels-150x100.jpg)
Bengaluru sees 19% hike in home sales: Report
![](https://www.udayavani.com/wp-content/uploads/2024/09/BSE_pti-1-150x84.jpg)
Sensex tanks 1,017 pts to close at 2-week low tracking weak global trends
![](https://www.udayavani.com/wp-content/uploads/2024/09/adaniG-150x84.jpg)
Mumbai college rejected him, Adani built $220 billion empire; delivers lecture at same college
MUST WATCH
Latest Additions
![](https://www.udayavani.com/wp-content/uploads/2024/09/Ganesh-Chaturthi-150x105.jpg)
Karnataka ushers in Ganesh Chaturthi with its customary fervour; political tussle over govt’s order
![](https://www.udayavani.com/wp-content/uploads/2024/09/Gen-Asim-Munir-Wikimedia-Commons-150x99.jpg)
Pakistan Army Chief acknowledges role of Pak army in Kargil war
![](https://www.udayavani.com/wp-content/uploads/2024/09/Infant-1-150x100.jpg)
Kushinagar: Man forced to ‘sell’ son for hospital fee, 5 arrested
![](https://www.udayavani.com/wp-content/uploads/2024/09/CBI-rep-agencies-1-150x113.jpg)
Ex-RG Kar hospital principal had criminal nexus with co-accused for wrongful gains: CBI
![](https://www.udayavani.com/wp-content/uploads/2024/09/rains-rep-PTI-150x84.jpg)
29 dead in Telangana due to heavy rains, floods
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.